Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Total Current Liabilities (2020 - 2026)

Privia Health has reported Total Current Liabilities over the past 6 years, most recently at $568.5 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 26.58% year-over-year to $568.5 million; the TTM value through Dec 2025 reached $568.5 million, up 26.58%, while the annual FY2025 figure was $568.5 million, 26.58% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $568.5 million at Privia Health, down from $582.9 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $582.9 million in Q3 2025 and troughed at $157.5 million in Q1 2021.
  • A 5-year average of $356.3 million and a median of $372.7 million in 2023 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: soared 62.64% in 2022 and later rose 16.07% in 2024.
  • Year by year, Total Current Liabilities stood at $190.5 million in 2021, then surged by 38.75% to $264.3 million in 2022, then surged by 46.42% to $387.0 million in 2023, then increased by 16.07% to $449.1 million in 2024, then rose by 26.58% to $568.5 million in 2025.
  • Business Quant data shows Total Current Liabilities for PRVA at $568.5 million in Q4 2025, $582.9 million in Q3 2025, and $534.9 million in Q2 2025.